AGAPE ATP CORPORATION Cost, Amortization
AGAPE ATP CORPORATION (ATPC) reported Cost, Amortization of $3.09 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSoldAmortization · last filed 2023-08-14
- AGAPE ATP CORPORATION cost, amortization for the quarter ending 2023-06-30 was $1.51K, a 243.05% increase year-over-year.
- AGAPE ATP CORPORATION cost, amortization for the quarter ending 2023-03-31 was $1.58K, a 245.20% increase year-over-year.
- AGAPE ATP CORPORATION cost, amortization for the quarter ending 2022-12-31 was $800.00, a 67.01% increase year-over-year.
- AGAPE ATP CORPORATION cost, amortization for the quarter ending 2022-09-30 was $425.00, a 10.71% decline year-over-year.
- AGAPE ATP CORPORATION cost, amortization for fiscal 2022 was $2.12K, a 8.21% increase from fiscal 2021.
- AGAPE ATP CORPORATION cost, amortization for fiscal 2021 was $1.96K, a 30.30% increase from fiscal 2020.
- AGAPE ATP CORPORATION cost, amortization for fiscal 2020 was $1.50K.
| Period end | Cost, Amortization 3 month | Cost, Amortization 6 month | Cost, Amortization 9 month | Cost, Amortization 12 month |
|---|---|---|---|---|
| 2023-06-30 | $1.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.09K 10-Q · filed 2023-08-14 | $3.89K derived: sum of 3 quarters · filed 2023-08-14 | $4.31K derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $1.58K 10-Q · filed 2023-05-15 | $2.38K derived: sum of 2 quarters · filed 2023-05-15 | $2.81K derived: sum of 3 quarters · filed 2023-05-15 | $3.25K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | $800.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.23K derived: sum of 2 quarters · filed 2023-03-31 | $1.66K derived: sum of 3 quarters · filed 2023-08-14 | $2.12K 10-K · filed 2023-03-31 |
| 2022-09-30 | $425.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $864.00 derived: sum of 2 quarters · filed 2023-08-14 | $1.32K 10-Q · filed 2022-11-14 | $1.80K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | $439.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $897.00 10-Q · filed 2023-08-14 | $1.38K derived: sum of 3 quarters · filed 2023-08-14 | $1.85K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $458.00 10-Q · filed 2023-05-15 | $937.00 derived: sum of 2 quarters · filed 2023-05-15 | $1.41K derived: sum of 3 quarters · filed 2023-05-15 | $1.91K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $479.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $955.00 derived: sum of 2 quarters · filed 2023-03-31 | $1.45K derived: sum of 3 quarters · filed 2023-03-31 | $1.96K 10-K · filed 2023-03-31 |
| 2021-09-30 | $476.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $972.00 derived: sum of 2 quarters · filed 2022-11-14 | $1.48K 10-Q · filed 2022-11-14 | $1.99K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $496.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.01K 10-Q · filed 2022-08-11 | $1.52K derived: sum of 3 quarters · filed 2022-08-11 | $2.03K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $510.00 10-Q · filed 2022-05-13 | $1.02K derived: sum of 2 quarters · filed 2022-07-05 | $1.53K derived: sum of 3 quarters · filed 2022-07-05 | |
| 2020-12-31 | $512.00 derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | $1.02K derived: sum of 2 quarters · filed 2022-07-05 | $1.50K 10-K/A · filed 2022-07-05 | |
| 2020-09-30 | $511.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-07-05 | $993.00 10-Q/A · filed 2022-07-05 | ||
| 2020-06-30 | $482.00 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |